PFG
SLS icon

Prosperity Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Prosperity Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,500
Closed -$29.8K – 205
2025
Q3 		$29.8K Buy
18,500
+2,000
+12% +$3.56K 0.01% 180
2025
Q2 		$36.1K Hold
16,500
– – 0.02% 163
2025
Q1 		$17.8K Buy
16,500
+5,000
+43% +$5.94K 0.01% 164
2024
Q4 		$12K Buy
+11,500
New +$13.1K 0.01% 172
2024
Q2 		– Sell
-25,385
Closed -$25.6K – 154
2024
Q1 		$25.6K Buy
+25,385
New +$21.3K 0.02% 144
2023
Q4 		– Sell
-24,800
Closed -$40.7K – 138
2023
Q3 		$40.7K Sell
24,800
-5,000
-17% -$7.89K 0.03% 112
2023
Q2 		$46.8K Buy
+29,800
New +$47.9K 0.04% 129

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return